1 year return (CAGR)
-
Braveheart Bio, Inc. Common Stock Exchange (NASDAQ, USD)
BRVE
27.45
+0.74 (+2.77%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.94B
Price/Sales
-
Ent value
2.02B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 26.82 |
| Daily high | 28.90 |
| Daily low | 26.22 |
| Daily Volume | 551K |
| All-time high | 30.00 |
| 1y analyst estimate | 44.33 |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BRVE | S&P500 | |
| Current price drop from All-time high | -8.50% | -3.06% |
| Highest price drop | -16.63% | -56.47% |
| Date of highest drop | 11 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -8.80% | -10.68% |
| Avg time to new high | 14 days | 12 days |
| Max time to new high | 28 days | 1805 days |
News
